| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - American Biologics Romania Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Current Assets | 1.195 | 1.183 | 1.163 | 1.142 | 1.120 | 1.098 | - | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Receivables | 1.125 | 1.113 | 1.095 | 1.074 | 1.054 | 1.034 | - | - | - | - |
| Cash | 70 | 70 | 69 | 67 | 66 | 65 | - | - | - | - |
| Shareholders Funds | 1.157 | 1.145 | 1.126 | 1.105 | 1.084 | 1.063 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 38 | 38 | 37 | 37 | 36 | 35 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - American Biologics Romania Srl